DOCSLIB.ORG

1123.Full.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1123.Full.Pdf Epidemiology/Health Services/Psychosocial Research ORIGINAL ARTICLE High Incidence of Tacrolimus-Associated Posttransplantation Diabetes in the Korean Renal Allograft Recipients According to American Diabetes Association Criteria 1 2 YOUNG MIN CHO, MD JONGWON HA, MD, PHD lograft rejection, posttransplantation dia- 1 2 KYONG SOO PARK, MD, PHD SANG JOON KIM, MD, PHD betes mellitus (PTDM) has become a 1 3 HYE SEUNG JUNG, MD BYOUNG DOO RHEE, MD, PHD 1 1 major drawback in its clinical application HYUN JUNG JEON, MD SEONG YEON KIM, MD, PHD 1 1 (8–12). A temporal trend of the incidence CURIE AHN, MD, PHD HONG KYU LEE, MD, PHD of PTDM has been demonstrated to show a bimodal pattern corresponding to the early kidney transplantation era using high-dose steroids in the 1960s and to the OBJECTIVE — The incidence of posttransplantation diabetes mellitus (PTDM) has been introduction of tacrolimus in the 1990s reported to vary according to different study populations or different definitions. In this study, (5). using American Diabetes Association criteria, the incidence and clinical characteristics of PTDM Tacrolimus inhibits the transcription of in Korean renal allograft recipients undergoing tacrolimus-based immunosuppression were the insulin gene by inhibition of calcineurin examined. after binding to FK506-binding protein 12 (FKBP12) (13,14). In contrast, sirolimus, RESEARCH DESIGN AND METHODS — A total of 21 patients taking tacrolimus as which also binds to FKBP12, interacts with primary immunosuppressant were recruited and tested with a serial 75-g oral glucose tolerance test at 0, 1, 3, and 6 months after renal transplantation. mammalian target of rapamycin, so-called mTOR, instead of calcineurin and fre- RESULTS — The cumulative incidence of PTDM was 52.4% at 1 month and 57.1% at 3 and quently causes hyperlipidemia by inhibi- 6 months. The baseline characteristics of the PTDM group were old age (especially Ͼ40 years), tion of insulin action (15). Tacrolimus- a high BMI, a high fasting glucose level, a high plasma insulin level, and increased insulin induced PTDM has been proven to be resistance. Among these parameters, old age was the only independent risk factor. The insulin reversible after withdrawing tacrolimus secretory capacity in the PTDM group was maximally suppressed 3 months after transplantation. (13,14,16), and we have recently reported a Thereafter, it was gradually restored along with dose reduction of tacrolimus. case showing complete insulin indepen- dence after severe diabetic ketoacidosis as- CONCLUSIONS — Routine screening for PTDM is necessary in patients over 40 years of age who are undergoing a relatively higher dose tacrolimus therapy during the early course of sociated with tacrolimus treatment (17). postrenal transplantation. It has been reported that PTDM is as- sociated with diabetic microvascular Diabetes Care 26:1123–1128, 2003 complications, an increased frequency of sepsis as a cause of death, and a risk of developing graft failure (18). Considering acrolimus is an effective alternative potential of tacrolimus is much higher the well-known serious clinical outcomes to cyclosporine as a primary immu- than that of cyclosporine in the early post- of hyperglycemia and the established nosuppressant after kidney trans- transplantation period (5–7). Despite its benefits of intensive glycemic control T (19,20), the chronic metabolic derange- plantation (1–4). The diabetogenic excellent prophylactic effect on renal al- ment in PTDM, even though the severity ●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●● of which is mild, could lead to many dia- From the 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; betes complications and should be cor- the 2Department of Surgery, Seoul National University College of Medicine, Seoul, Korea; and the 3Depart- rected appropriately. Therefore, in this ment of Internal Medicine, Inje University Medical College, Seoul, Korea. study, to define PTDM we used the Amer- Address correspondence and reprint requests to Kyong Soo Park, MD, PHD, Department of Internal ican Diabetes Association (ADA) criteria Medicine, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, Seoul, 110-744, Korea. E-mail: [email protected]. for the diagnosis of diabetes (21), which is Received for publication 12 September 2002 and accepted in revised form 10 January 2003. more stringent than ever. Abbreviations: 2-h PG, 2-h plasma glucose during an OGTT; AUC, area under the curve; FKBP, FK506- Ethnic difference contributes to the binding protein 12; FPG, fasting plasma glucose; HCV, hepatitis C virus; HOMA-BC, homeostasis model variable susceptibility to developing assessment for ␤-cell function; HOMA-IR, HOMA for insulin resistance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; OGTT, oral glucose tolerance test; PTDM, posttransplantation diabetes mellitus. PTDM (5,12,22,23). Interestingly, most A table elsewhere in this issue shows conventional and Syste`me International (SI) units and conversion type 2 diabetic patients in Korea are char- factors for many substances. acterized by defects in insulin secretion DIABETES CARE, VOLUME 26, NUMBER 4, APRIL 2003 1123 PTDM associated with tacrolimus Table 1—Comparison of baseline clinical characteristics Measurements The 75-g oral glucose tolerance test Non-PTDM PTDM P (OGTT) was used to assess the glucose tolerance and to measure the insulin re- n 912 sponse to a glucose load on four occasions Age 27 Ϯ 241Ϯ 4 Ͻ0.05 (day –1 and months 1, 3, and 6). OGTT Sex (male:female) 2:7 9:3 Ͻ0.05 was not performed (at months 3 and 6) in BMI (kg/m2) 20.1 Ϯ 1.0 23.1 Ϯ 0.9 Ͻ0.05 the patients who developed PTDM re- Family history of diabetes* 1/9 (11.1%) 3/12 (25.0%) NS quiring insulin or oral antidiabetic ther- Systolic blood pressure (mmHg) 144 Ϯ 3 140 Ϯ 6NSapy (n ϭ 4). All tests were performed in Diastolic blood pressure (mmHg) 86 Ϯ 380Ϯ 3NSthe morning after an overnight fast, and Fasting plasma glucose (mmol/l) 4.9 Ϯ 0.3 5.6 Ϯ 0.2 Ͻ0.05 the blood pressure, height, and weight Ϯ Ϯ HbA1c (%) 5.0 0.2 4.8 0.3 NS were measured before OGTT of each visit. Ϯ Ϯ Fasting plasma C-peptide (nmol/l) 2.4 0.6 2.3 0.2 NS The HbA1c, HLA type, anti-hepatitis C vi- Fasting plasma insulin (pmol/l) 55.8 Ϯ 35.2 80.4 Ϯ 18.9 Ͻ0.05 rus (HCV) antibody, total cholesterol, tri- HOMA-IR 2.5 Ϯ 1.7 3.5 Ϯ 0.9 Ͻ0.05 glyceride, and HDL cholesterol levels HOMA-BC 95.5 Ϯ 36.3 121.5 Ϯ 27.7 NS were measured by routine assays in the Insulinogenic index 2.3 Ϯ 1.4 5.8 Ϯ 4.5 NS Department of Clinical Pathology at Seoul Total cholesterol (mmol/l) 4.1 Ϯ 0.3 4.1 Ϯ 0.1 NS National University Hospital. The LDL Triglycerides (mmol/l) 1.1 Ϯ 0.1 1.6 Ϯ 0.3 NS cholesterol level was calculated by Friede- HDL cholesterol (mmol/l) 1.1 Ϯ 0.1 1.1 Ϯ 0.1 NS wald’s equation. The fasting plasma insu- LDL cholesterol (mmol/l) 2.5 Ϯ 0.2 2.3 Ϯ 0.2 NS lin and C-peptide levels were determined Data are means Ϯ SEM unless otherwise indicated. *Family history of clinical diabetes in a first-degree by radioimmunoassay (BioSource Europe relative. NS, not significant. S.A., Nivelles, Belgium) in a single large batch. Using the plasma glucose and insulin rather than insulin resistance (24,25). ceived a renal allograft from a living- data obtained from the OGTT, the ho- Thus, tacrolimus-based immunosuppres- related donor, and 3 patients received an meostasis model assessment of insulin re- sion, which causes ␤-cell toxicity and allograft from their spouse. Patients sistance (HOMA-IR) and ␤-cell function subsequent insulin secretory defects, may undergoing cadaver-donor kidney trans- (HOMA-BC) were calculated (26). The exert more detrimental effects in the Ko- plantation were not included. The insulinogenic index, which has been rean population. primary causes of renal failure were hy- demonstrated to show an excellent corre- In this background, we examined the pertension (n ϭ 3), IgA nephropathy (n ϭ lation with acute insulin response (27), incidence and clinical characteristics of 3), glomerulonephritis (n ϭ 2), systemic was used to estimate the early insulin se- PTDM defined by ADA criteria in the Ko- lupus erythematosus (n ϭ 2; they did not cretion using OGTT data. rean patients receiving tacrolimus-based take glucocorticoids at the time of trans- immunosuppression after kidney trans- plantation, because their disease was clin- Definition plantation. ically inactive), Alport’s syndrome (n ϭ In this study, the ADA criteria were used 1), solitary kidney (n ϭ 1), and an un- to diagnose PTDM. Briefly, the symptoms RESEARCH DESIGN AND known primary pathology (n ϭ 9). No of typical diabetes plus casual plasma glu- METHODS cose concentration Ն11.1 mmol/l, fasting patient tested positive for anti-GAD anti- plasma glucose (FPG) Ն7.0 mmol/l with bodies. Subjects no calorie intake for at least 8 h, or 2-h The following criteria were used to deter- plasma glucose during an OGTT (2-h PG) mine which patients were eligible to par- Ն11.1 mmol/l was defined as PTDM. In Immunosuppression ticipate in the study: age 18 years or older, addition, impaired fasting glucose (IFG) recipients of a kidney allograft, no known The immunosuppressive regimen con- and impaired glucose tolerance (IGT) history of clinical diabetes, no current use sisted of tacrolimus and glucocorticoid in were defined as FPG Ն6.1Ͻ7.0 mmol/l of steroids or other immunosuppressive all patients. The initial tacrolimus dose and 2-h PG Ն7.8 Ͻ11.1 mmol/l, agents, and no previous history of organ was 0.075 mg/kg body wt given twice respectively.
Load more

Recommended publications
  • Novichok Agent - Wikipedia
    18-3-2018 Novichok agent - Wikipedia Novichok agent Novichok (Russian: Новичо́к, "newcomer") is a series of nerve agents the Soviet Union and Russia developed between 1971 and 1993.[a][2][3] Russian scientists who developed the agents claim they are the deadliest nerve agents ever made, with some variants possibly five to eight times more potent than VX,[4][5] and others up to ten times more potent than soman.[6] They were designed as part of a Soviet program codenamed "FOLIANT".[7][1] Five Novichok variants are believed to have been weaponised for military use.[8] The most versatile was A-232 (Novichok-5).[9] Novichok agents have never been used on the battlefield. Theresa May, Prime Minister of the United Kingdom, said that one such agent was used in the poisoning of Sergei and Yulia Skripal in England in March 2018.[10] Russia officially denies producing or researching Novichok agents.[11] In 2013, the Organisation for the Prohibition of Chemical Weapons Scientific Advisory Board reported that it had insufficient information to comment on the existence or properties of Novichok agents,[12] and in 2011 it noted there was no peer reviewed paper on Novichok agents in scientific literature.[13] Contents Design objectives Disclosure Development and test sites Description of Novichok agents Chemistry Effects Use Poisoning of Kivelidi Poisoning of Sergei and Yulia Skripal See also References Further reading External links Design objectives These agents were designed to achieve four objectives:[14][15] To be undetectable using standard 1970s and 1980s NATO chemical detection equipment; To defeat NATO chemical protective gear; To be safer to handle; To circumvent the Chemical Weapons Convention list of controlled precursors, classes of chemical and physical form.
    [Show full text]
  • Verification of Chemical Warfare Agent Exposure in Human Samples
    Toxichem Krimtech 2013;80(Special Issue):288 Verification of chemical warfare agent exposure in human samples Paul W. Elsinghorst, Horst Thiermann, Marianne Koller Institut für Pharmakologie und Toxikologie der Bundeswehr, München Abstract Aim: This brief presentation provides an overview of methods that have been developed for the verification of human exposure to chemical warfare agents. Methods: GC–MS detection of nerve agents (V- and G-type) has been carried out with respect to unreacted agents as well as enzyme-bound species and metabolites. Methods involving di- rect SPE from plasma, fluoride-induced release of protein-bound nerve agents in plasma and analysis of their metabolites in plasma and urine have been developed. Exposure to blistering agents, i.e., sulfur mustard, has been verified by GC–MS detection of the unreacted agent in plasma and by LC– and GC–MS analysis of its metabolites in urine. Results: After incorporation nerve agents quickly bind to proteins, e.g., acetylcholinesterase, butyrylcholinesterase or serum albumin, and only small parts remain freely circulating for a few hours (G-type) or up to 2 days (V-type). Concurrently they are converted to O-alkyl methylphosphonic acids by phosphotriesterases and/or simply by aqueous hydrolysis. As a re- sult, different biomarkers can be detected depending on the time passed between exposure and sampling. Unreacted V-type agents can be detected in plasma for 2 days, the O-alkyl methyl- phosphonic acids in plasma for about 2–4 days and in urine for up to 1 week. Fluoride-indu- ced release of protein-bound nerve agents can be carried out until 3 weeks post exposure.
    [Show full text]
  • Warning: the Following Lecture Contains Graphic Images
    What the новичок (Novichok)? Why Chemical Warfare Agents Are More Relevant Than Ever Matt Sztajnkrycer, MD PHD Professor of Emergency Medicine, Mayo Clinic Medical Toxicologist, Minnesota Poison Control System Medical Director, RFD Chemical Assessment Team @NoobieMatt #ITLS2018 Disclosures In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards, the American Nurses Credentialing Center’s Commission (ANCC) and the Commission on Accreditation for Pre-Hospital Continuing Education (CAPCE), states presenters must disclose the existence of significant financial interests in or relationships with manufacturers or commercial products that may have a direct interest in the subject matter of the presentation, and relationships with the commercial supporter of this CME activity. The presenter does not consider that it will influence their presentation. Dr. Sztajnkrycer does not have a significant financial relationship to report. Dr. Sztajnkrycer is on the Editorial Board of International Trauma Life Support. Specific CW Agents Classes of Chemical Agents: The Big 5 The “A” List Pulmonary Agents Phosgene Oxime, Chlorine Vesicants Mustard, Phosgene Blood Agents CN Nerve Agents G, V, Novel, T Incapacitating Agents Thinking Outside the Box - An Abbreviated List Ammonia Fluorine Chlorine Acrylonitrile Hydrogen Sulfide Phosphine Methyl Isocyanate Dibotane Hydrogen Selenide Allyl Alcohol Sulfur Dioxide TDI Acrolein Nitric Acid Arsine Hydrazine Compound 1080/1081 Nitrogen Dioxide Tetramine (TETS) Ethylene Oxide Chlorine Leaks Phosphine Chlorine Common Toxic Industrial Chemical (“TIC”). Why use it in war/terror? Chlorine Density of 3.21 g/L. Heavier than air (1.28 g/L) sinks. Concentrates in low-lying areas. Like basements and underground bunkers. Reacts with water: Hypochlorous acid (HClO) Hydrochloric acid (HCl).
    [Show full text]
  • Chemical Warfare Agents
    Manuscript for Kirk-Othmer Encyclopedia of Chemical Technology August 2019 CHEMICAL WARFARE AGENTS This is the pre-print manuscript of an article published in the Kirk-Othmer Encyclopedia of Chemical Technology: https://onlinelibrary.wiley.com/doi/book/10.1002/0471238961 The published version of the article is available at the Wiley website: https://onlinelibrary.wiley.com/doi/10.1002/0471238961.0308051308011818.a01.pub3 How to cite: Costanzi, S. (2020). Chemical Warfare Agents. In Kirk‐Othmer Encyclopedia of Chemical Technology, (Ed.). doi:10.1002/0471238961.0308051308011818.a01.pub3 Stefano Costanzi Department of Chemistry and Center for Behavioral Neuroscience American University, Washington, D.C. [email protected] Chemical weapons are weapons that exploit the toxicity of chemicals to bring about death or harm. The toxic chemicals on which chemical weapons are based are known as chemical warfare agents. The elimination of this entire category of weapons is the aim of the Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction, also known as Chemical Weapons Convention or CWC, which was opened for signature in 1993 and entered into force in 1997. Administered and implemented by the Hague- based Organisation for the Prohibition of Chemical Weapons (OPCW), the CWC is an international treaty that enjoys almost universal embracement, having been ratified or acceded by 193 States Parties. Importantly, the CWC poses a complete and absolute ban on chemical weapons, mandating State Parties to renounce “(a) to develop, produce, otherwise acquire, stockpile or retain chemical weapons, or transfer, directly or indirectly, chemical weapons to anyone; (b) to use chemical weapons; (c) to engage in any military preparations to use chemical weapons; (d) to assist, encourage or induce, in any way, anyone to engage in any activity prohibited to a State Party” under the Convention (CWC Article II, Paragraph 1) (1-3).
    [Show full text]
  • Instruction Manual for Coding Multiple Causes of Fetal Death, 2013
    INSTRUCTIONS FOR THE AUTOMATED CLASSIFICATION OF THE INITIATING AND MULTIPLE CAUSES OF FETAL DEATHS, 2013 SECTION I: General Concepts For Coding Fetal Deaths A. INTRODUCTION This manual provides instructions to NCHS mortality medical coders and nosologists for coding multiple causes of fetal death reported on the 2003 Revision of the Fetal Death Reports filed in the states. These mortality coding instructions are used by the National Center for Health Statistics (NCHS), which is the Federal agency responsible for the compilation of U.S. statistics on causes of fetal death. NCHS is part of the Centers of Disease Control and Prevention. In coding causes of fetal death, NCHS refers to the World Health Organization’s most recent revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) for processing the data for fetal mortality tabulation. Beginning with fetal deaths occurring in 1999, ICD-10 has been used for coding and classifying causes of fetal death. This revision of the Classification is published by the World Health Organization (WHO) and consists of three volumes. Volume 1 contains a list of three-character categories, the tabular list of inclusions, and the four-character sub-categories. The supplementary Z code Classification appears in Volume 1 but is not used for classifying mortality cause of death data, including fetal deaths. Optional fifth characters are provided for certain categories and an optional independent four-character coding system is provided to classify histological varieties of neoplasm, prefixed by the letter M (for morphology) and followed by a fifth character indicating behavior. These optional codes are not used at NCHS.
    [Show full text]
  • Dissertation Tony E
    RATIONAL DESIGN OF ORGANOPHOSPHORUS HYDROLASE FOR THE DEGRADATION AND DETECTION OF NEUROTOXIC PESTICIDES AND CHEMICAL WARFARE AGENTS A Dissertation by TONY ELVERN REEVES Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY May 2006 Major Subject: Biochemistry RATIONAL DESIGN OF ORGANOPHOSPHORUS HYDROLASE FOR THE DEGRADATION AND DETECTION OF NEUROTOXIC PESTICIDES AND CHEMICAL WARFARE AGENTS A Dissertation by TONY ELVERN REEVES Submitted to the Office of Graduate Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Approved by: Chair of Committee, James Wild Committee Members, Evelyn Castiglioni Janet Grimsley Paul Lindahl Martin Scholtz Head of Department, Greg Reinhart May 2006 Major Subject: Biochemistry iii ABSTRACT Rational Design of Organophosphorus Hydrolase for the Degradation and Detection of Neurotoxic Pesticides and Chemical Warfare Agents. (May 2006) Tony Elvern Reeves, B.S.; M.S., Tarleton State University Chair of Advisory Committee: Dr. James R. Wild It is critical to consider the balance between the catalytic capabilities of an enzyme and the inherent structural stability of the protein when developing enzymes for specific applications. Rational site directed mutagenesis has been used to explore the role of residues 254 and 257 in the global stability and catalytic specificities of organophosphorus hydrolase (OPH, EC 3.1.8.1). Substitution of residues H254 and H257, which are located near the active site, had a marked effect on both the global stability and substrate specificity of the enzyme. For example, the ΔGT for the double mutation Co2+ H254R H257L (RL) enzyme variant was 19.6 kcal/mol, 5.7 kcal/mol less than that of the wild type enzyme.
    [Show full text]
  • Therapy of Nerve Agent Poisoning O F O P Nu Enhanced O Elimination by Scavengers
    TThheerraappyy ooff NNeerrvvee AAggeenntt PPooiissoonniinngg –– UUpp--ddaattee aanndd NNeeww AApppprrooaacchheess H. Thiermann and F. Worek Bundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, Germany Toxicology Symposium of the Low Lands 9th June 2017 Ghent, Belgium Nerve Agents and other Organophosphorus Compounds G - Agents Tabun (GA), Sarin (GB), Cyclosarin (GF), Soman (GD) (and Analogs) V - Agents VX, Russian VX (VR), Chinese VX (CVX) (and Analogs) OP- Pesticides Diethyl-type, Dimethyl-type, hundreds of other compounds! Characteristics of Poisoning by Nerve Agents Generally assumed: patients exposed up to 5x LD50 Inhalative G-Type Nerve Agent Poisoning - Immediate onset of cholinergic crisis - Short persistence of nerve agent in the body Percutaneous V-type Nerve Agent Poisoning - Prolonged onset of cholinergic crisis - Persistence of nerve agent over several days in the body Effects of Organophosphorus Compounds Mechanism: - inhibition of AChE - accumulation of ACh - disturbance of cholinergic functions Clinical Challenge of Nerve Agent Poisoning Signs and symptoms Nerve agent poisoning Slight Moderate Severe Miosis / lacrimation Local fasciculations Hypersalivation / sweating Nausea Vomiting / defacation / emiction Bronchocontriction / bronchorrhoe Bradycardia / circulatory depression Respiratory depression Convulsions Coma Worek et al. Arch Toxicol 2016 Effects of Organophosphorus Compounds Mechanism: - inhibition of AChE - accumulation of ACh - disturbance of cholinergic functions Life threatening effects: - bronchoconstriction/
    [Show full text]
  • Counteracting Poisoning with Chemical Warfare Nerve Agents Arh Hig Rada Toksikol 2020;71:266-284 266
    Maček Hrvat N, Kovarik Z. Counteracting poisoning with chemical warfare nerve agents Arh Hig Rada Toksikol 2020;71:266-284 266 Review DOI: 10.2478/aiht-2020-71-3459 Counteracting poisoning with chemical warfare nerve agents Nikolina Maček Hrvat and Zrinka Kovarik Institute for Medical Research and Occupational Health, Zagreb, Croatia [Received in July 2020; Similarity Check in July 2020; Accepted in November 2020] Phosphylation of the pivotal enzyme acetylcholinesterase (AChE) by nerve agents (NAs) leads to irreversible inhibition of the enzyme and accumulation of neurotransmitter acetylcholine, which induces cholinergic crisis, that is, overstimulation of muscarinic and nicotinic membrane receptors in the central and peripheral nervous system. In severe cases, subsequent desensitisation of the receptors results in hypoxia, vasodepression, and respiratory arrest, followed by death. Prompt action is therefore critical to improve the chances of victim’s survival and recovery. Standard therapy of NA poisoning generally involves administration of anticholinergic atropine and an oxime reactivator of phosphylated AChE. Anticholinesterase compounds or NA bioscavengers can also be applied to preserve native AChE from inhibition. With this review of 70 years of research we aim to present current and potential approaches to counteracting NA poisoning. KEY WORDS: bioscavenger; cholinesterases; cyclosarin; Novichoks; organophosphate; sarin; tabun; VX Organophosphates (OPs) are ester, amide, or thiol for improvement through recent developments in NA derivatives of phosphorous, phosphonic, or phosphinic poisoning treatment and prophylaxis/pretreatment. acids. They occur in important biomolecules like DNA and RNA, some cofactors and coenzymes, phosphoproteins, NERVE AGENTS and phospholipids, but can also be synthesised. The first OP compounds were synthesised in the early 19th century (1, 2).
    [Show full text]
  • An in Vitro Comparative Study on the Reactivation of Nerve Agent- Inhibited Guinea Pig and Human Acetylcholinesterases by Oximes
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln US Army Research U.S. Department of Defense 2007 An In Vitro Comparative Study on the Reactivation of Nerve Agent- Inhibited Guinea Pig and Human Acetylcholinesterases by Oximes Chunyuan Luo Min Tong Nageswararao Chilukuri Karen Brecht Donald M. Maxwell See next page for additional authors Follow this and additional works at: https://digitalcommons.unl.edu/usarmyresearch Part of the Operations Research, Systems Engineering and Industrial Engineering Commons Luo, Chunyuan; Tong, Min; Chilukuri, Nageswararao; Brecht, Karen; Maxwell, Donald M.; and Saxena, Ashima, "An In Vitro Comparative Study on the Reactivation of Nerve Agent-Inhibited Guinea Pig and Human Acetylcholinesterases by Oximes" (2007). US Army Research. 42. https://digitalcommons.unl.edu/usarmyresearch/42 This Article is brought to you for free and open access by the U.S. Department of Defense at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in US Army Research by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Authors Chunyuan Luo, Min Tong, Nageswararao Chilukuri, Karen Brecht, Donald M. Maxwell, and Ashima Saxena This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/ usarmyresearch/42 Biochemistry 2007, 46, 11771-11779 11771 An In Vitro Comparative Study on the Reactivation of Nerve Agent-Inhibited Guinea Pig and Human Acetylcholinesterases by Oximes Chunyuan Luo,*,‡ Min Tong,‡ Nageswararao Chilukuri,‡ Karen Brecht,§ Donald M. Maxwell,§ and Ashima Saxena‡ Department of Molecular Pharmacology, DiVision of Biochemistry, Walter Reed Army Institute of Research, SilVer Spring, Maryland 20910, and U.S. Army Medical Research Institute of Chemical Defense, Edgewood, Maryland 21010 ReceiVed May 23, 2007; ReVised Manuscript ReceiVed July 31, 2007 ABSTRACT: The reactivation of nerve agent-inhibited acetylcholinesterase (AChE) by oxime is the most important step in the treatment of nerve agent poisoning.
    [Show full text]
  • Chemical Weapons Part 1 by Mark Bishop Chemical Weapons (CW)
    Science and Technology Chemical Weapons Part 1 By Mark Bishop Chemical Weapons (CW) • Chemical weapons are, “Any chemical which through its chemical action on life processes can cause death, temporary incapacitation or permanent harm to humans or animals. This includes all such chemicals, regardless of their origin or of their method of production, and regardless of whether they are produced in facilities, in munitions or elsewhere.” (OPCW) Special gas mask for dogs-1917 Types of Chemical Weapons – Choking agents (e.g. chlorine, phosgene) – Blistering agents (e.g. sulfur mustard) – Blood agents (e.g. hydrogen cyanide) – Nerve agents (e.g. sarin, VX, novichok) – Toxins (e.g. ricin) – Tearing agents (e.g. CS) – Opiate-like agents ( e.g. fentanyl) – Psychochemical Incapacitants (e.g. BZ) Assignment • This will Begin after the fourth chemistry module lecture. • You will divide yourselves into groups of four. • Two people in each group will pretend to Be either terrorists or a country’s military leaders and plan a simulated chemical weapons attack. – Identify your goal (high lethality, get attention, take over territory, etc.) – Choose the target. – Choose the chemical weapon – Choose the means of dispersal. – Determine a source of the chemical weapon. • Two people in each group will act as the security team attempting to stop the attack and minimize damage. Assignment • The terrorists or military leaders will provide subtle clues to the security people. • The security pair can tell the terrorists what they are looking for, and the terrorists will provide clues based on these searches. • Based on the clues they have received, the security team will develop a plan to stop the attack, and failing that, a plan to minimize the effects of the attack.
    [Show full text]
  • Phosgene Oxime
    Phosgene oxime From Wikipedia, the free encyclopedia Jump to navigation Jump to search Phosgene oxime Names IUPAC name N-(dichloromethylidene)hydroxylamine Other names dichloroformaldoxime, dichloroformoxime, hydroxycarbonimidic dichloride, CX Identifiers Y CAS Number • 1794-86-1 • Interactive image 3D model (JSmol) ChemSpider • 59024 Y • 65582 PubChem CID UNII • G45S3149SQ Y • DTXSID9075292 CompTox Dashboard (EPA) show InChI • InChI=1S/CHCl2NO/c2-1(3)4-5/h5H Y Key: JIRJHEXNDQBKRZ-UHFFFAOYSA-N Y • InChI=1/CHCl2NO/c2-1(3)4-5/h5H Key: JIRJHEXNDQBKRZ-UHFFFAOYAP show SMILES • Cl/C(Cl)=N\O Properties CHCl NO Chemical formula 2 Molar mass 113.93 g·mol−1 Appearance colorless crystalline solid or yellowish-brown liquid[1] Melting point 35 to 40 °C (95 to 104 °F; 308 to 313 K)[1] Boiling point 128 °C (262 °F; 401 K)[1] 70%[1] Solubility in water Hazards Main hazards highly toxic Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is Y N ?) Infobox references Chemical compound Phosgene oxime, or CX, is an organic compound with the formula Cl2CNOH. It is a potent chemical weapon, specifically a nettle agent. The compound itself is a colorless solid, but impure samples are often yellowish liquids. It has a strong, disagreeable odor and a violently irritating vapor. Contents • 1 Preparation and reactions • 2 Safety • 2.1 Decontamination, treatment, and handling properties • 3 References • 4 External links Preparation and reactions[edit] Phosgene oxime can be prepared by reduction of chloropicrin using a combination of tin metal and hydrochloric acid as the source of the active hydrogen reducing acent: Cl3CNO2 + 4 [H] → Cl2C=N−OH + HCl + H2O The observation of a transient violet color in the reaction suggests intermediate formation of trichloronitrosomethane (Cl3CNO).
    [Show full text]
  • Threat by Nerve Agents: Update of Diagnostic and Therapeutic Strategies!
    Threat by nerve agents: Update of diagnostic and therapeutic strategies! H. Thiermann and F. Worek Bundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, Germany Congress of the European Society of Emergency Hot Topic Lecture Wednesday 12th September 2018 Glasgow, United Kingdom Scenarios of an Attack with Chemical Warfare Agents – Attack on Civilian Population 1 Scenarios of an Attack with Chemical Warfare Agents – Targeted Homicidal Attack Nerve Agents and other Organophosphorus Compounds G - Agents Tabun (GA), Sarin (GB), Cyclosarin (GF), Soman (GD) (and Analogs) R R X V - Agents VX, Russian VX (VR), Chinese VX (CVX) (and Analogs) OP- Pesticides Diethyl-type, Dimethyl-type, hundreds of other compounds! 2 Characteristics of Poisoning by Nerve Agents Generally assumed: patients exposed up to 5x LD50 Inhalative G-Type Nerve Agent Poisoning - Immediate onset of cholinergic crisis - Short persistence of nerve agent in the body Percutaneous V-type Nerve Agent Poisoning - Prolonged onset of cholinergic crisis - Persistence of nerve agent over several days in the body Organophosphorus Compound Threats © 2017 by InstPharmToxBw Worek et al. Arch Toxicol 2016 3 Effects of Organophosphorus Compounds Mechanism: - inhibition of AChE - accumulation of ACh - disturbance of cholinergic functions https://www.stern.de/politik/ausland/syrien--angriff-auf-klinik- mit-mutmasslichen-giftgas-opfern-7398534.html Cholinesterases – Reason of Confusion AChE (EC 3.1.1.7) • found mostly in nervous tissue and blood (red blood cells) • primates have the highest activity, rats one tenth and cats roughly 1 % compared to human RBCs Pl-ChE (EC 3.1.1.8) • synthesis in the liver • capable of splitting several cholinesters, incl. acetylcholine, highest activity with butyrylcholine Confusion Often reported: determination of AChE in human plasma with acetylcholine or acetylthiocholine as substrate: in fact activity of BChE was determined! Blum et al.
    [Show full text]